Business Wire

O-RAN-ALLIANCE-E.V.

16.3.2021 12:30:05 CET | Business Wire | Press release

Share
O-RAN ALLIANCE Announces New Board Member and Introduces Minimum Viable Plan to Expedite the Delivery of Essential O-RAN Functions

As of February 23, 2021, the O-RAN ALLIANCE welcomes DISH Network as a new member of its Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005553/en/

“Carriers around the world are recognizing the importance of building next-generation, programmable networks that are open, intelligent and flexible, making the work of the O-RAN ALLIANCE more critical than ever,” said Sidd Chenumolu, DISH vice president of technology development. “At DISH, we are in a unique position as we build a 5G network entirely upon O-RAN standards, and the work of this organization creates a unified roadmap as our partners join us in developing a disaggregated and open RAN. We look forward to playing a continued role in the success of the O-RAN ALLIANCE and the development of standards that enhance connectivity worldwide.”

O-RAN ALLIANCE’s Minimum Viable Plan (MVP) Towards Commercial O-RAN Solutions

O-RAN’s specification effort, open software development, as well as testing and integration, will focus on priorities set by its operator members. This approach will allow the O-RAN ecosystem players to prioritize the delivery of a minimum viable set of end-to-end O-RAN solutions applicable in commercial networks.

The first release of the MVP includes already published specifications and additional work items in the area of:

  • Open fronthaul specifications provide fully specified control, user and synchronization interface, management plane interface between O-RU and O-DU, and relevant conformance and interoperability tests, enabling multi-vendor interoperability.
  • Open transport defines the requirements of xhaul transport, proposes the best practices of deploying WDM and IP technologies in xhaul.
  • Open hardware offers hardware reference designs for different modes of indoor picocell, outdoor microcell, outdoor Macrocell and open fronthaul gateway to accelerate the use of whitebox and facilitate RAN ecosystem diversity.
  • Open stack provides a software reference design for O-CU/O-DU architecture, interfaces, internal modules, and APIs, to promote and guide the open source software development.
  • Open cloud presents O-Cloud reference design with the fundamental synchronization requirements and real life deployment recommendations.
  • Testing and integration sets the criteria and guidelines for the formation of Open Testing and Integration Centers (OTICs) , ensuring consistency and quality of the testing of O-RAN products and solutions.

Subsequent O-RAN releases will extend the MVP with additional features and functionalities based on continuing surveys and updates of operators’ deployment priorities.

28 New or Updated O-RAN Specifications Released since November 2020

On February 26, 2021, the O-RAN ALLIANCE published another 28 specification documents, including 10 new titles. For more details on the new specifications, please check this O-RAN blog post . To download O-RAN specifications, please proceed to www.o-ran.org/specifications .

O-RAN Open Summit Held on February 25, 2021 Available for Re-play

The O-RAN Open Summit on February 25, 2021 has gained attention with more than 2500 global visitors. The recording of Open Summit is available at the O-RAN website . The recording includes full content of the event, including five keynotes:

  • Opening address - Alex Jinsung Choi , COO of O-RAN ALLIANCE and SVP Technology Strategy & Innovation of Deutsche Telekom
  • Chairman address - Andre Fuetsch , Chairman of the O-RAN ALLIANCE and Chief Technology Officer of AT&T
  • O-RAN Technical progress - Chih-Lin I , Co-Chair of O-RAN Technical Steering Committee and China Mobile Chief Scientist, Wireless Technologies, China Mobile Research Institute
  • Testing and Integration Focus Group update - David Orloff , Co-chair of O-RAN Testing and Integration Focus Group, AT&T
  • O-RAN Software Community update - Jack Murray , Co-Chair of OSC Technical Oversight Committee, AT&T

The event recording also includes the panel discussion on ‘Paths to O-RAN implementation ’ providing valuable insights on possible ways towards open RAN introduction in the public mobile networks. The panelists represent a great variety of players in the O-RAN ecosystem: AT&T, NTT DOCOMO, Orange, TIM, O-RAN ALLIANCE, Intel, Keysight, ONF, Nokia and Radisys.

About O-RAN ALLIANCE

The O-RAN ALLIANCE is a world-wide community of more than 270 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information please visit www.o-ran.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Danish C-UAS Startup Shotling Raises €700K Oversubscribed Pre-Seed (Myriad-IPO CLUB-EIFO) for Anti-Drone Shotgun2.2.2026 07:35:00 CET | Press release

Shotling, a Danish defense technology startup specializing in kinetic short-range counter-UAS (C-UAS) systems, today announced the closing of a pre-seed financing round with €700K committed out of a targeted €500K. The round is led by Myriad Defense Fund, with co-investment from IPO CLUB’s Fund II America 2030, and a non-dilutive match-loan granted by EIFO, the Export and Investment Fund of Denmark, supporting Shotling’s mission to deliver rapid-fire modular shotgun systems against FPV drones and loitering munitions—as the global counter-UAS market accelerates towards $10B by 2030, with kinetic defense segment showing strong momentum (25%+ CAGR). Shotling’s rotary shotgun system provides unmatched close-range defense (50–100m) against the rapidly growing threat of kamikaze drones, combining a gatling-style design, with novel, high-capacity magazines, and firing rates up to 3,000 RPM using standard or tungsten-based 12-gauge shells. With deep expertise in weapons engineering and active

Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission2.2.2026 07:00:00 CET | Press release

The United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults RelabotulinumtoxinA is designed to optimize molecule integrity to deliver fast onset of action as early as Day 1 and sustained results for six months for frown lines and crow’s feet and has been approved in over 20 markets, including in the European Union1-3 Galderma (SIX: GALD) today announced that the U.S. FDA has accepted the BLA resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults. Galderma has worked closely with the U.S. FDA to implement adjustments to its manufacturing process. Galderma is committed to using its expertise and heritage in the neuromodulator space to develop next-generation

High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 20261.2.2026 08:00:00 CET | Press release

Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131322203/en/ Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibility (Image: Lorient) The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic safety protocols. His involvement provided a prestigious validation of the technical excellence of Lorient. Alongside him, prominent Korean medical experts Dr. Won Lee and Dr. Do Young Rhee shared clinical insights that drew widespread praise from the international medical community. Central to the academic discussions was Lorient’s "safety-first" philosophy for its premium HA filler ran

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye